Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population
Jan O. Kemnade, Marcus A. Florez, Anita L. Sabichi, Jun Zhang, Pavan Jhaveri, George Chen, Albert C. Chen, Courtney N. Miller-Chism, Shaun Bulsara, Susan G. Hilsenbeck, David J. Hernandez, Heath D. Skinner, Vlad C. Sandulache
Topics & Concepts
MedicineMetforminHead and neck cancerInternal medicineHead and neck squamous-cell carcinomaRadiosensitizerPopulationOncologyCohortCancerClinical trialAdverse effectRetrospective cohort studyPhases of clinical researchChemoradiotherapySurgeryRadiation therapyInsulinEnvironmental healthMetabolism, Diabetes, and CancerCancer Risks and FactorsCancer, Lipids, and Metabolism